Nutriband Inc.
02/13/2026 | Press release | Distributed by Public on 02/13/2026 15:59
Regulation FD Disclosure (Form 8-K)
Item 7.01. Regulation FD Disclosure.
Our Board of Directors at a meeting held today approved the termination immediately of the Company's agreement for the sale of our subsidiary, Pocono Pharmaceuticals, Inc., to Earth Vision Bio Inc., due to the purchaser's failure to pay applicable late fees under the purchase agreement for their not closing on the December 31, 2025 closing date under the purchase agreement. We had received $30,000 in late fees, but have not received any further payments since January 21, 2026.
Nutriband Inc. published this content on February 13, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on February 13, 2026 at 21:59 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]